Inhaled Pharmaceutical Product Development Perspectives

Challenges and Opportunities

de

Éditeur :

Elsevier Science


Paru le : 2017-11-23



eBook Téléchargement , DRM LCP 🛈 DRM Adobe 🛈 ebook sans DRM
Lecture en ligne (streaming)
68,52

Téléchargement immédiat
Dès validation de votre commande
Ajouter à ma liste d'envies
Image Louise Reader présentation

Louise Reader

Lisez ce titre sur l'application Louise Reader.

Description
Inhaled Pharmaceutical Product Development Perspectives: Challenges and Opportunities describes methods and procedures for consideration when developing inhaled pharmaceuticals, while commenting on product development strategies and their suitability to support regulatory submission. It bridges the gap between the aspirations of scientists invested in new technology development and the requirements that must be met for any new product. The book brings together emerging analytical and inhalation technologies, providing perspectives that illuminate formulation and device design, development, regulatory compliance, and practice. Focusing on underlying scientific and technical principles known to be acceptable from the current regulatory perspective, this monograph will remain useful as a high-level guide to inhaled product development for the foreseeable future. - Discusses development strategies and best practices in the context of regulatory requirements - Written by a broadly qualified expert drawing on the knowledge and critical opinions of key individuals in the field - Includes a foreword by Charles G. Thiel
Pages
110 pages
Collection
n.c
Parution
2017-11-23
Marque
Elsevier Science
EAN papier
9780128122099
EAN PDF
9780128123362

Informations sur l'ebook
Nombre pages copiables
11
Nombre pages imprimables
11
Taille du fichier
2232 Ko
Prix
68,52 €
EAN EPUB SANS DRM
9780128123362

Prix
68,52 €

Anthony J. Hickey, PhD, DSc, currently serves as a distinguished fellow and senior research pharmacologist at RTI International. He has more than 30 years of academic and research experience in the areas of pulmonary biology, aerosol physics, powder dynamics, pharmacokinetics and drug disposition, formulation design, and device development. His research has focused on improving understanding of the physiology, pharmacology, and immunology of the lungs. Throughout his career, Dr. Hickey has worked on intranasal and inhaled vaccine development and drug delivery for diseases affecting the respiratory tract, including asthma, chronic obstructive lung disease, tuberculosis, and cystic fibrosis. He has also studied the performance of powders and particles in drug and vaccine delivery systems. He received his PhD and DSc degrees in pharmaceutical sciences from the University of Aston in Birmingham, a master's degree in toxicology from the University of Birmingham, and a bachelor's degree in biology from Portsmouth Polytechnic.

Suggestions personnalisées